Phase III Trial of Doxorubicin /Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D (AC-D) as Front-Line Chemotherapy for Metastatic Breast Cancer: Japan Clinical Oncology Group Trial (JCOG9802)
Phase of Trial: Phase III
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Docetaxel (Primary) ; Cyclophosphamide; Doxorubicin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 01 Jul 2009 Primary endpoint 'Time to treatment failure' has not been met.
- 05 Jun 2009 New trial record.